Ileal Bile Acid Transporter Inhibitor [EPC]: Side Effects & Safety Data for 2 Drugs
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
Ileal Bile Acid Transporter Inhibitor [EPC] includes 2 drugs with a combined 1,022 adverse event reports in the FDA FAERS database. Compare their safety profiles, side effects, and outcomes below.
2
Drugs in Class
1,022
Combined Reports
All Ileal Bile Acid Transporter Inhibitor [EPC] Drugs Ranked by Reports
| Drug | Brand Name | Reports | Deaths | Hosp. | Death Rate |
|---|---|---|---|---|---|
| MARALIXIBAT | Livmarli | 799 | 14 | 98 | 1.8% |
| ODEVIXIBAT | BYLVAY | 223 | 10 | 43 | 4.5% |
Common Side Effects in Ileal Bile Acid Transporter Inhibitor [EPC] Drugs
| Side Effect | Reports | Deaths |
|---|---|---|
| Pruritus | 276 | 3 |
| Off label use | 143 | 5 |
| Diarrhoea | 136 | 1 |
| Drug ineffective | 98 | 3 |
| Hepatic enzyme increased | 66 | 0 |
| Liver transplant | 63 | 2 |
| Vomiting | 49 | 0 |
| Blood bilirubin increased | 46 | 2 |
| Abdominal pain | 41 | 0 |
| Product dose omission issue | 41 | 0 |